Application no. and date | 14775675.3 (espacenet) (Federated) (European Patent Register), 20140224 | Patent/reg. no. and date | DK/EP 2978419, 20200415 | Publication date | 20160203 | Priority no. and date | US 201361804690 P, 20130324, US 201314140083, 20131224 | EP pub. no. and date |
EP 2978419 20160203 | Effective date | | Applicant/owner | Amylyx Pharmaceuticals Inc., 43 Thorndike St
Cambridge, MA 02141, US | Applicant ref. no. | P72665DK01 | Inventor | COHEN, Joshua B., 118 Huntington Ave Apt. 306
Boston, Massachusetts 02116-5760, US, KLEE, Justin, 169 Monsignor O'Brien Highway No.403
Cambridge, Massachusetts 02141, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/185 (2006.01) , A61K 31/19 (2006.01) , A61K 31/192 (2006.01) , A61K 31/195 (2006.01) , A61K 31/575 (2006.01) , A61P 25/00 (2006.01) , A61P 25/28 (2006.01) | Title | SAMMENSÆTNINGER TIL FORBEDRING AF CELLELEVEDYGTIGHED OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | Int. application no. | US2014018040 | Int. publication no. | WO2014158547 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|